Maybe even Tuesday. If the FDA meets the PDUFA target date of Sunday 19th and advises the company same day (yes they do work weekends), BMY could conceivably release that the next day at any point (including pre-market or after hours in the US). That’s anywhere from Monday night to late morning Tuesday for us here.
Alternatively FDA might clear the decision off its desk sometime on Friday US time, meaning sometime tomorrow if BMY rushes out with it (or as above Mon night/late Tues morn here).
Ann: Immutep to present Phase IIb breast cancer data at ESMO 2022, page-6
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $480.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 32.0¢ | $1.703M | 5.215M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 211685 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 279000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |